Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation

被引:23
|
作者
Ru, Yuhua [1 ,2 ]
Chen, Jia [1 ,2 ]
Wu, Depei [1 ,2 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Peoples R China
[2] Soochow Univ, Collaborat Innovat Ctr Hematol, Inst Blood & Marrow Transplantat, Suzhou 215006, Peoples R China
基金
美国国家科学基金会; 国家重点研发计划;
关键词
EB virus; hematopoietic stem cell transplantation; lymphoproliferative disease; BONE-MARROW-TRANSPLANTATION; EBV REACTIVATION; RISK-FACTORS; VIRAL LOAD; PREEMPTIVE RITUXIMAB; PROLONGED HYPOGAMMAGLOBULINEMIA; ALLOGENEIC TRANSPLANTATION; HEART-TRANSPLANTATION; EUROPEAN CONFERENCE; PEDIATRIC-PATIENTS;
D O I
10.1111/ejh.13131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epstein-Barr virus (EBV) viremia and post-transplant lymphoproliferative disease (PTLD) are severe complications after hematopoietic stem cell transplantation (HSCT). A series of risk factors have been found to predict EBV viremia and PTLD, including the T-cell depletion, reduced intensity conditioning, and alternative donor. The rituximab pre-emptive therapy could improve PTLD prognosis significantly, but the trigger of initiating rituximab pre-emptive therapy has not been well established. Additionally, EBV-specific cytotoxic T cell (CTL) is a promising approach to treat EBV-PTLD.
引用
收藏
页码:283 / 290
页数:8
相关论文
共 50 条
  • [1] Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation
    Liu, Q. -F.
    Fan, Z. -P.
    Luo, X. -D.
    Sun, J.
    Zhang, Y.
    Ding, Y. -Q.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (04) : 284 - 291
  • [2] Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease
    Meerbach, Astrid
    Wutzler, Peter
    Haefer, Ralf
    Zintl, Felix
    Gruhn, Bernd
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (03) : 441 - 454
  • [3] Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation
    Feuillet, S.
    Meignin, V.
    Briere, J.
    Brice, P.
    Rocha, V.
    Socie, G.
    Tazi, A.
    Bergeron, A.
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2009, 2 : 11 - 15
  • [4] Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant
    Rouce, Rayne H.
    Louis, Chrystal U.
    Heslop, Helen E.
    CURRENT OPINION IN HEMATOLOGY, 2014, 21 (06) : 476 - 481
  • [5] Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation
    Uhlin, Michael
    Wikell, Helena
    Sundin, Mikael
    Blennow, Ola
    Maeurer, Markus
    Ringden, Olle
    Winiarski, Jacek
    Ljungman, Per
    Remberger, Mats
    Mattsson, Jonas
    HAEMATOLOGICA, 2014, 99 (02) : 346 - 352
  • [6] Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant
    Rodriguez, Lizamarie Bachier
    Shore, Tsiporah B.
    Gergis, Usama
    Hsu, Jingmei
    Phillips, Adrienne A.
    Mayer, Sebastian A.
    Rennert, Hanna
    Van Besien, Koen
    BLOOD, 2017, 130
  • [7] Epstein-Barr virus and post-transplant lymphoproliferative disease
    Holmes, RD
    Sokol, RJ
    PEDIATRIC TRANSPLANTATION, 2002, 6 (06) : 456 - 464
  • [8] Management of Epstein-Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
    Liu, Li
    Liu, Qifa
    Feng, Sizhou
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [9] Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
    Tsao, Shu-Yi
    Chang, Kung-Chao
    Chen, Ya-Ping
    Yeh, Yu-Min
    Su, Wu-Chou
    Chen, Tsai-Yun
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 113 - 114
  • [10] Epstein-Barr virus related post-transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation
    Lindsay, Julian
    Yong, Michelle K.
    Greenwood, Matthew
    Kong, David C. M.
    Chen, Sharon C. A.
    Rawlinson, William
    Slavin, Monica
    REVIEWS IN MEDICAL VIROLOGY, 2020, 30 (04)